FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Meeting of the Oncologic Drugs Advisory Committee (ODAC) FDA White Oak Campus, Building 31, the Great Room (Rm[removed]White Oak Conference

First Page		Document Content
Medicine Pharmacology Clinical pharmacology Therapeutics United States Public Health Service Center for Drug Evaluation and Research National Institute of Diabetes and Digestive and Kidney Diseases Oncology Drug Advisory Committee Dermatologic and Ophthalmic Drugs Advisory Committee Food and Drug Administration Pharmaceutical sciences Clinical research		FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Meeting of the Oncologic Drugs Advisory Committee (ODAC) FDA White Oak Campus, Building 31, the Great Room (Rm[removed]White Oak Conference Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 38,22 KB Share Document on Facebook

	Missing Data Issues in Regulatory Clinical Trials Lisa M. LaVange, PhD Office of Biostatistics OTS/CDER/US FDA DocID: 139er - View Document
	Federal Register / Vol. 80, No[removed]Friday, April 3, [removed]Notices trading in a range from 0 to 1⁄4 percent. The Committee directs the Desk to undertake open market operations as necessary to maintain such conditions DocID: 10Jhy - View Document
	FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Joint Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) and the Ophthalmic Devices Panel of the Medical Devices DocID: XQdQ - View Document
	FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Joint Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) and the Ophthalmic Devices Panel of the Medical Devices DocID: XQ6P - View Document
	CARDIOVASCULAR AND RENAL DRUGS ADVISORY COMMITTEE MEMBERS (Voting) DocID: X4oB - View Document